FibroBiologics wins European patent for enhancing fibroblast therapeutic activity
FBLG•FibroBiologics won a European patent for methods to condition fibroblasts with platelet-rich plasma, including claims involving cytokines and applications in angiogenesis and spinal disc regeneration.
1. Patent scope
The patent covers methods using platelet-rich plasma to condition fibroblasts for stronger regenerative activity, including cytokines such as FGF-alpha or FGF-beta. It also provides protection for angiogenesis-related applications and targets spinal disc regeneration. The grant expands FibroBiologics’ portfolio of more than 270 issued or pending patents.
